VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
180 hedge funds and large institutions have $783M invested in Meridian Bioscience Inc in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 74 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
36% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 74
Holders
180
Holding in Top 10
2
Calls
$7M
Puts
$7.48M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$4.71M | |
| 3 | +$3.14M | |
| 4 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
+$2.63M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.4M |
Top Sellers
| 1 | -$28.8M | |
| 2 | -$7.13M | |
| 3 | -$3.06M | |
| 4 |
MAP
Moody Aldrich Partners
Marblehead,
Massachusetts
|
-$3.04M |
| 5 |
Millennium Management
New York
|
-$2.5M |